Entering into a new market, companies that deal with medical devices need to be aware of more than the regulatory procedure alone. Every region has its own requirements with regard to classification of the device, approach to submission, technical data, proof requirements, registration procedures, labeling, and post-market obligations.
A regulatory strategy that has been successfully employed in one market might need some changes before being used in another. Regulatory differences, expectations of the regulator, need for local representation, commercialization plan – all of this may affect the way the strategy is to be designed for market entry.
Elexes helps medical devices manufacturers with the market specific regulatory strategy and implementation in several major markets: FDA in the USA, Health Canada, EU MDR/IVDR, MHRA/UKCA in the UK, TGA in Australia and CDSCO in India.
Our approach considers the device, intended use, claims, available evidence, manufacturer responsibilities, and business objectives to help companies plan appropriate regulatory activities.
Learn more Regulatory Consulting
Entering a new market with a medical device? Get expert advice on regulatory requirements and documentation from our team.
Regulations of medical devices are aimed at ensuring that the product complies with the requirements related to safety, performance, and quality before and after entering the market. However, the way these requirements are applied differs between jurisdictions.
Market-specific considerations may include:
⦿ Device classification and risk categorization
⦿ Applicable regulatory pathways
⦿ Technical documentation expectations
⦿ Clinical or performance evidence requirements
⦿ Quality management system expectations
⦿ Registration or listing obligations
⦿ Local representative or economic operator requirements
⦿ Labeling and post-market obligations
The appropriate regulatory strategy depends on several factors, including:
⦿ Device type and technology
⦿ Classification
⦿ Intended use and claims
⦿ Manufacturer role
⦿ Existing approvals or certifications
⦿ Available technical and clinical evidence
⦿ Commercialization plans
This will allow the manufacturer to be able to avoid unnecessary gaps in documentation and synchronize development with market needs.
Learn more: Medical Device Regulatory Strategy Services
Elexes offers regulatory consulting services in priority medical device markets around the world. Each market has a different regulatory scheme, but our process is geared towards knowing the regulatory requirement of the device and crafting a suitable roadmap.
The US FDA regulates medical devices follow a risk-based methodology in which the regulatory requirements are determined by the device classification, purpose, technology, and controls.
For the specific device, the manufacturer may be required to assess the pathways such as 510(k), De Novo request, PMD Approval, or other applicable pathway.
Key considerations may include:
⦿ Device classification and product code assessment
⦿ Regulatory pathway considerations
⦿ Submission strategy
⦿ Technical documentation review
⦿ Performance testing considerations
⦿ Software, cybersecurity, and human factors requirements (where applicable)
⦿ Post-market obligations
Elexes provides support in assessing the FDA requirements, developing the submission strategy and preparing documents according to the FDA requirements.
Health Canada regulates medical devices based on a classification-based approach in which the licensing requirements are determined by the risk class of the device and applicable requirements.
Potential factors for the manufacturers that intend to enter the Canadian market might be:
⦿ Device classification
⦿ Medical Device Licence (MDL) requirements
⦿ Manufacturer licensing obligations
⦿ Quality management system requirements
⦿ Authorized representative requirements where applicable
⦿ Labeling and post-market responsibilities
Elexes provides support in assessing the regulatory requirements in Canada and developing the regulatory strategy and documentation requirements.
The regulatory framework set up by the European Union mandates manufacturers to show compliance with relevant regulations prior to placing their medical devices or in vitro diagnostic devices into the market.
The regulatory approach depends on factors such as the classification of the device, its intended use, risk profile, requirement for clinical data, etc.
Key considerations may include:
⦿ Device classification under MDR or IVDR
⦿ Technical documentation requirements
⦿ Clinical evaluation or performance evaluation
⦿ Quality management system requirements
⦿ Role of Notified Body (where applicable)
⦿ Economic operator responsibilities
⦿ Post-market surveillance requirement
Elexes supports manufacturers with EU regulatory strategy, documentation planning, and lifecycle regulatory activities.
After the UK regulatory framework changed, manufacturers placing their products into the Great Britain market should address applicable MHRA registration and conformity assessment requirements.
Regulatory considerations may include:
⦿ Device classification
⦿ UK responsible person requirements where applicable
⦿ Registration obligations
⦿ Conformity assessment approach
⦿ Labeling requirements
⦿ Post-market responsibilities
Elexes provides support to manufacturers in understanding the UK market requirements and development of their regulatory strategy.
The Therapeutic Goods Administration (TGA) regulates medical devices in Australia through a framework based on classification, conformity assessment, Australian Register of Therapeutic Goods (ARTG) inclusion, and compliance requirements.
These include:
⦿ Device classification
⦿ Conformity assessment requirements
⦿ ARTG inclusion requirements
⦿ Sponsor responsibilities
⦿ Technical documentation expectations
⦿ Post-market obligations
Elexes helps the manufacturers of medical devices who are planning to enter the market in Australia to understand the requirements of regulation and develop a strategy for support of documentation.
The medical devices in India are regulated by the Central Drugs Standard Control Organization (CDSCO).
Manufacturers entering the Indian market may need to evaluate:
⦿ Device classification
⦿ Import or manufacturing licensing requirements
⦿ Authorized representative requirements
⦿ Documentation requirements
⦿ Labeling obligations
⦿ Regulatory submissions
Elexes helps the manufacturers of medical devices who are planning to enter the market in India to understand the requirements of regulation and develop a strategy for the same.
Manufacturers entering multiple markets often face challenges due to differences in regulatory expectations.
The classification of a device in one market is not necessarily equivalent to its classification in another jurisdiction. Reassessment of device classification may be required under local rules and intended use of the device.
Markets may differ in expectations related to clinical evidence, performance testing, software validation, usability engineering, or other supporting documentation.
Some markets require local representatives, sponsors, or economic operators who have defined regulatory responsibilities.
Existing documentation may support multiple market submissions; however, gaps may need to be addressed based on market-specific expectations.
Market entry does not terminate with authorization of the device. Changes, registrations, and other activities need to be managed by the manufacturer throughout the product’s life cycle.
Elexes helps medical device manufacturers develop practical market-entry strategies based on their product characteristics, regulatory objectives, and commercialization plans.
Our support may include:
⦿ Regulatory pathway assessment
⦿ Market-specific regulatory gap assessment
⦿ Device classification review
⦿ Submission planning
⦿ Technical documentation strategy
⦿ Evidence planning
⦿ Regulatory documentation support
⦿ Registration and lifecycle support
⦿ Coordination with local regulatory resources where required
For companies expanding internationally, Elexes can also support coordination of appropriate locally based regulatory or RA/QA resources depending on market requirements.
Regulatory requirements are determined by the interaction of several factors.
A suitable regulatory approach depends on understanding the relationship between the product, market, and business objectives.
Key factors include:
⦿ Device type and technology
⦿ Intended use and claims
⦿ Regulatory classification
⦿ Manufacturer role
⦿ Existing approvals
⦿ Available evidence
⦿ Commercialization timeline
⦿ Target markets
Planning for regulations at the early stages could assist in determining all necessary requirements and priorities and documentation.
Use our Medical Device Market Entry Readiness Checklist to review key regulatory considerations before expanding into new markets.
The checklist provides an initial assessment of areas such as classification, documentation, evidence planning, registration requirements, and post-market considerations.
Expanding into new markets requires understanding how regulatory expectations apply to your specific device, evidence, and business objectives.
Elexes provides assistance to device manufacturers with practical regulations guidance and documentation planning worldwide.
No. Regulatory pathways vary based on market requirements, device classification, intended use, claims, technology, and available evidence.
Elexes supports regulatory consulting across the US FDA, Health Canada, EU MDR/IVDR, UK MHRA/UKCA, Australia TGA, and India CDSCO markets.
Existing documentation may support additional market submissions, but it often requires review and adaptation based on local regulatory expectations.
Yes. Elexes supports international regulatory planning and can help coordinate appropriate local regulatory or RA/QA resources where required.
Our process begins with an in-depth consultation where we learn about your medical device, its intended use, and your specific goals. This helps us tailor our assessment to your unique needs.
Our team of experts is well-versed in global medical device regulations, including FDA submissions, CE marking, TGA requirement, Health Canada approvals, ISO, and more. We stay up-to-date with the latest changes in the regulatory landscape.
We will conduct a comprehensive review of your existing documentation, including design files, clinical data, quality management systems, and risk assessments.
Our consultants will perform a gap analysis to identify any areas where your device may fall short of compliance. This forms the basis for our recommendations.
Based on our findings, we will provide you with detailed recommendations and a roadmap for achieving compliance. This may involve revising documentation, conducting additional testing, or making necessary design changes.
Our services don't stop with just the assessment. We offer ongoing support to guide you through the compliance process, helping you address any challenges that may arise.
Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.
Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.
Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.
At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.
We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.
We offer different services that will help you not only keep your product well in boundaries of regulations but also speed up the entire approval process. Some of these services are -
CEO Masterlink, Arizona
CEO Novasignal, Los Angeles
President ViDava, Florida
Sr. Exe Treedental, Hong Kong
Manager Outset Medical, California
CTO Jana Care, Massachusetts
MD Blackrock Pharma, England
VP Regulatory AliveCor, California
Owner Liz Inc., Arizona
CEO Radformation, New York
Never miss out on any important update on the regulatory & compliance industry across the globe. Subscribe to our newsletter now.
Copyright 2025, Elexes Medical Consulting Pvt. Ltd. All Rights Reserved
Working Hours : Monday to Friday 9:00 AM - 7:00 PM
Team Elexes 
